WHO advises doctors not to use Gilead’s remdesivir for COVID-19
[ad_1] The World Health Organization has recommended not using Gilead Sciences Inc.’s remdesivir to treat COVID-19 hospital patients less than a month after U.S. regulators granted the drug early approval. “There is currently no evidence that this improves survival or the need for ventilation,” said a group of experts convened by the WHO to develop … Read more